Designation of 14 Counties as High Intensity Drug Trafficking Areas, 10289 [2016-04291]

Download as PDF Federal Register / Vol. 81, No. 39 / Monday, February 29, 2016 / Notices 10289 ATTACHMENT 1—GENERAL TARGET SCHEDULE FOR PROCESSING AND RESOLVING REQUESTS FOR ACCESS TO SENSITIVE UNCLASSIFIED NON-SAFEGUARDS INFORMATION IN THIS PROCEEDING—Continued Day Event/activity A + 28 ...... Deadline for submission of contentions whose development depends upon access to SUNSI. However, if more than 25 days remain between the petitioner’s receipt of (or access to) the information and the deadline for filing all other contentions (as established in the notice of hearing or opportunity for hearing), the petitioner may file its SUNSI contentions by that later deadline. (Contention receipt +25) Answers to contentions whose development depends upon access to SUNSI. (Answer receipt +7) Petitioner/Intervenor reply to answers. Decision on contention admission. A + 53 ...... A + 60 ...... >A + 60 .... OVERSEAS PRIVATE INVESTMENT CORPORATION BILLING CODE 7590–01–P EXECUTIVE OFFICE OF THE PRESIDENT Designation of 14 Counties as High Intensity Drug Trafficking Areas Office of National Drug Control Policy. ACTION: Notice of HIDTA designations. The Director of the Office of National Drug Control Policy designated 14 additional counties as High Intensity Drug Trafficking Areas (HIDTA) pursuant to 21 U.S.C. 1706. The new counties are (1) Blount County, Tennessee and Carroll and Grayson Counties (including the Independent City of Galax) in Virginia as part of the Appalachia HIDTA; (2) Escambia and Santa Rosa Counties in Florida as part of the Gulf Coast HIDTA; (3) Muskegon County, Michigan as part of the Michigan HIDTA; (4) Bristol County, Massachusetts as part of the New England HIDTA; (5) Broome and Ulster Counties in New York as part of the New York/New Jersey HIDTA; (6) Linn County, Oregon as part of the OregonIdaho HIDTA; (7) McIntosh and Pittsburg Counties in Oklahoma as part of the Texoma HIDTA; (8) Carroll County, Maryland and Jefferson County, West Virginia as part of the Washington/ Baltimore HIDTA. SUMMARY: FOR FURTHER INFORMATION CONTACT: asabaliauskas on DSK5VPTVN1PROD with NOTICES Proposed Submission of Information Collection for OMB Review; Comment Request; Administrative Appeals Thursday, March 17, 2016, 2 p.m. (Open Portion) 2:15 p.m. (Closed Portion). TIME AND DATE: Office of National Drug Control Policy AGENCY: PENSION BENEFIT GUARANTY CORPORATION Sunshine Act Meeting Notice [FR Doc. 2016–04337 Filed 2–26–16; 8:45 am] Questions regarding this notice should be directed to Michael K. Gottlieb, National HIDTA Program Director, Office of National Drug Control Policy, Executive Office of the President, Washington, DC 20503; (202) 395–4868. Offices of the Corporation, Twelfth Floor Board Room,1100 New York Avenue NW., Washington, DC. PLACE: Meeting OPEN to the Public from 2 p.m. to 2:15 p.m. Closed portion will commence at 2:15 p.m. (approx.) STATUS: MATTERS TO BE CONSIDERED: 1. President’s Report 2. Confirmation—Tracey Webb 3. Minutes of the Open Session of the December 10, 2015 Board of Directors Meeting FURTHER MATTERS TO BE CONSIDERED: (Closed to the Public 2:15 p.m.): 1. Finance Project—Indonesia 2. Finance Project—India 3. Finance Project—India 4. Finance Project—Guinea 5. Finance Project—Cambodia 6. Finance Project—Cambodia 7. Finance Project—Global 8. Minutes of the Closed Session of the December 19, 2015 Board of Directors Meeting 9. Formation of a Risk Committee of the Board 10. Reports 11. Pending Projects CONTACT PERSON FOR MORE INFORMATION: Information on the meeting may be obtained from Catherine F. I. Andrade at (202) 336–8768, or via email at Catherine.Andrade@opic.gov. Dated: January 14, 2016. Michael Passante, Deputy General Counsel. Dated: February 25, 2016. Catherine F. I. Andrade, Corporate Secretary, Overseas Private Investment Corporation. [FR Doc. 2016–04291 Filed 2–26–16; 8:45 am] [FR Doc. 2016–04476 Filed 2–25–16; 4:15 pm] BILLING CODE 3280–F5–P BILLING CODE 3210–01–P VerDate Sep<11>2014 19:23 Feb 26, 2016 Jkt 238001 PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 Pension Benefit Guaranty Corporation. ACTION: Notice of intent to request extension of OMB approval of information collection. AGENCY: The Pension Benefit Guaranty Corporation (‘‘PBGC’’) intends to request the Office of Management and Budget (‘‘OMB’’) to extend approval, under the Paperwork Reduction Act, of a collection of information under its regulation on Rules for Administrative Review of Agency Decisions. This notice informs the public of PBGC’s intent and solicits public comment on the collection of information. DATES: Comments should be submitted by April 29, 2016. ADDRESSES: Comments may be submitted by any of the following methods: Federal eRulemaking Portal: https:// www.regulations.gov. Follow the Web site instructions for submitting comments. Email: paperwork.comments@ pbgc.gov. Fax: 202–326–4224. Mail or Hand Delivery: Office of the General Counsel, Pension Benefit Guaranty Corporation, 1200 K Street NW., Washington, DC 20005–4026. PBGC will make all comments available on its Web site, www.pbgc.gov. Copies of the collection of information may also be obtained without charge by writing to the Disclosure Division of the Office of the General Counsel of PBGC at the above address or by visiting the Disclosure Division or calling 202–326–4040 during normal business hours. (TTY and TDD users may call the Federal relay service toll-free at 1–800–877–8339 and ask to be connected to 202–326–4040.) PBGC’s regulation on Administrative Appeals may be accessed on PBGC’s Web site at www.pbgc.gov. SUMMARY: E:\FR\FM\29FEN1.SGM 29FEN1

Agencies

[Federal Register Volume 81, Number 39 (Monday, February 29, 2016)]
[Notices]
[Page 10289]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04291]


=======================================================================
-----------------------------------------------------------------------

EXECUTIVE OFFICE OF THE PRESIDENT

Office of National Drug Control Policy


Designation of 14 Counties as High Intensity Drug Trafficking 
Areas

AGENCY: Office of National Drug Control Policy.

ACTION: Notice of HIDTA designations.

-----------------------------------------------------------------------

SUMMARY: The Director of the Office of National Drug Control Policy 
designated 14 additional counties as High Intensity Drug Trafficking 
Areas (HIDTA) pursuant to 21 U.S.C. 1706. The new counties are (1) 
Blount County, Tennessee and Carroll and Grayson Counties (including 
the Independent City of Galax) in Virginia as part of the Appalachia 
HIDTA; (2) Escambia and Santa Rosa Counties in Florida as part of the 
Gulf Coast HIDTA; (3) Muskegon County, Michigan as part of the Michigan 
HIDTA; (4) Bristol County, Massachusetts as part of the New England 
HIDTA; (5) Broome and Ulster Counties in New York as part of the New 
York/New Jersey HIDTA; (6) Linn County, Oregon as part of the Oregon-
Idaho HIDTA; (7) McIntosh and Pittsburg Counties in Oklahoma as part of 
the Texoma HIDTA; (8) Carroll County, Maryland and Jefferson County, 
West Virginia as part of the Washington/Baltimore HIDTA.

FOR FURTHER INFORMATION CONTACT: Questions regarding this notice should 
be directed to Michael K. Gottlieb, National HIDTA Program Director, 
Office of National Drug Control Policy, Executive Office of the 
President, Washington, DC 20503; (202) 395-4868.

    Dated: January 14, 2016.
Michael Passante,
Deputy General Counsel.
[FR Doc. 2016-04291 Filed 2-26-16; 8:45 am]
BILLING CODE 3280-F5-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.